Kura Signs Leukemia Pact with Kyowa Kirin After Losing Race to Syndax
The agreement will give Kuro enough capital to support the development and launch of its menin inhibitor ziftomenib.
Kura Signs Leukemia Pact with Kyowa Kirin After Losing Race to Syndax Read More »
